Causaly’s Post

In my recent conversation with CNBC International, I discussed our new partnership with Sanofi and how we’re using Quantitative #AI to revolutionize biomarker discovery. This collaboration leverages our Large Quantitative Models (#LQMs) to accelerate the development of blood tests that can more accurately detect disease progression and patient health status. LQMs also promise to transform the traditionally hit-or-miss nature of drug development. Today, about 90% of drugs in clinical trials fail. By using AI trained on physics and chemistry, we’re helping biopharma companies like Sanofi get closer to effective diagnostics and treatments—faster, less expensively, and with a greater impact on patient outcomes. Watch the full interview to learn more about how we’re driving real change in the biopharma industry. https://bit.ly/4fkHyNe #DrugDiscovery #Biomarkers #HealthcareInnovation

Presenting React4life's MIVO® Platform, a groundbreaking invention in #organ on a chip #technology, designed to revolutionize #biomedical research. MIVO® replicates human tissue complexity and simulates systemic drug interactions, providing an advanced, high-throughput system for #DrugScreening and #DiseaseModeling. By leveraging human-relevant models, MIVO® empowers #PharmaceuticalCompanies, #ResearchCenters and #hospitals to accelerate drug discovery, reduce development costs, and improve therapeutic outcomes. This innovative platform bridges the gap between preclinical testing and clinical results, offering insight into how drugs interact within the human body. With React4life, you're equipped to explore new frontiers in #PersonalizedMedicine, delivering faster, more accurate solutions for patients worldwide. Learn how MIVO® is transforming the future of biomedical research at www.react4life.com or connect with Silvia Scaglione. #BiomedicalInnovation #PharmaTech #ResearchExcellence #DrugDiscovery #PrecisionMedicine

Digital twins of cells to precision medicine 🚀 Exciting news in AI-driven drug discovery! French startup DeepLife has secured a $10M Series A funding round to advance their platform, which creates "digital twins" of cells. This innovative approach enables pharmaceutical companies to simulate drug effects on cellular models, accelerating the repurposing of existing medications for new therapeutic uses. By leveraging AI to predict cellular responses, DeepLife is paving the way for more efficient and personalized healthcare solutions. This aligns with my vision of transitioning from reactive sickcare to proactive healthcare, where digital twins play a crucial role in anticipating and managing health outcomes. Kudos to Jonathan Baptista and team #digitaltwins #pharma #drugdiscovery #omics #multiomics Digital Twin Consortium Sven Eyckerman VIB

NEW Editorial Feature: Explore the latest advancements in cell line development and how they're driving innovation in drug discovery, disease research, and biotherapeutics production. This feature highlights expert insights into the technologies shaping the future of biotech. Visit it here: https://lnkd.in/eXRBYubE #CellLineDevelopment #Biotech #DrugDiscovery #Research #Biotherapeutics

🚀 Breaking News in Biopharma! 🚀 VedTechBio has officially launched RxAgentAI™, a cutting-edge AI and ML platform designed to transform decision-making for stakeholders in the life sciences industry. This innovative platform features specialized agents — Biology Agent, Chemistry Agent, and Clinical Agent — to provide precise, AI-powered insights across drug discovery, development, and clinical applications. In addition to this major launch, VedTechBio has also announced a significant drug discovery collaboration with RenaissThera, focusing on developing novel therapies for metabolic diseases like Obesity and Type 2 Diabetes. By combining VedTechBio’s generative AI technology with RenaissThera’s expertise, this partnership aims to accelerate the development of small-molecule drugs, addressing unmet medical needs in these critical areas. This is a huge leap forward for AI-driven innovation in pharma, and it’s exciting to see how RxAgentAI™ will reshape the future of healthcare. 💡💊 #AIinPharma #DrugDiscovery #ArtificialIntelligence #HealthcareInnovation #LifeSciences #MachineLearning #MetabolicDiseases #PharmaCollaborations

I attended a enlightening webinar on "Decoding Pharma in Critical Care"! organized by IPA-SF. The insights into the complexities of drug development and delivery in ICU settings were eye-opening. Learned about the advancements in precision medicine and how it's transforming patient outcomes. Key takeaways: The evolving landscape of critical care medications The urgent need for cost-effective critical care drugs The role of technology in optimizing drug therapy The importance of collaborative research for better patient care.

🚀 AI-powered Drug Discovery: The pharmaceutical industry is seeing a revolution! AI and Machine Learning models are speeding up the process of drug discovery, cutting years off development timelines. 🧬💊 Just this year, several companies have announced breakthroughs in using AI to find new drug candidates for diseases like cancer and Alzheimer's. 🌍 Exciting times ahead for AI and healthcare! #AI #Healthcare #DataScience #MachineLearning #DrugDiscover

🔬 Advancing Ex-Vivo Models with an Integrative Approach 🔬 Incorporating functional testing with viability assessments in 3D biological samples allows for a deeper and more precise understanding of drug responses. This advanced approach enhances the predictive accuracy of preclinical models, leading to a more efficient drug development process. By identifying successful drug candidates early and optimizing therapeutic strategies, researchers can reduce time and costs, thus offering safer and more effective therapies. Ultimately, this integration improves patient outcomes by ensuring that treatments are tailored to individual needs, enhancing both their safety and efficacy. #3DBiologicalSamples #FunctionalTesting #PreCure

NEW Editorial Feature: Explore the latest advancements in cell line development and how they're driving innovation in drug discovery, disease research, and biotherapeutics production. This feature highlights expert insights into the technologies shaping the future of biotech. Visit it here: https://lnkd.in/exNyNEb3 #CellLineDevelopment #Biotech #DrugDiscovery #Research #Biotherapeutics

📺 Catch up with our recent webinar hosted by Reuters Events Pharma, where we discussed the advantages of AI at the point of care for pharma. Hear from experts from AstraZeneca, Genentech, and IPG Health on how point-of-care AI is setting new benchmarks for commercial success and transforming care delivery. Watch the webinar replay and reshare with your colleagues: https://lnkd.in/g_nzGJfR #pointofcareAI #PharmaAI #CareDelivery